Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults
The George Institute for
The George Institute for Global Health received funding from the Oxford Martin School from 2010 - 2017. Although funding of the programme has finished, Professor Kazem Rahimi remains as Lead Researcher of the Oxford Martin Programme on Deep Medicine.
We are dedicated to the formulation, evaluation and implementation of innovative strategies for managing the healthcare challenges facing the world in the 21st century.
In the coming decades, healthcare systems in all regions of the world will face an increasing demand for essential health services, largely as a consequence of an ageing population and an increasing burden of chronic disease.
It is now apparent that no global health agenda is complete without consideration of the chronic disease burden and the strategies for its management. Much of our work aims at providing evidence that will directly inform policy and practice.
In the Aftermath of the National Children’s Study Is Large Birth Cohort Data Still a Priority?
Bending the blood pressure curve down: are we succeeding?
Blood Pressure and Risk of Vascular Dementia
Women's Health: a new global agenda
Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies
Objectively Measured Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective Cohort Study
Usual blood pressure and risk of new onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies
Birthweight and Childhood Cancer: Preliminary Findings from the International Childhood Cancer Cohort Consortium (I4C)
Worldwide access to treatment for end-stage kidney disease: a systematic review
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
Is the planet full?
Creating the Future Economy- WEF Summer Davos 2012
Statins are unlikely to prevent blood clots
Care delivery for heart failure